FUNCTIONALIZED STILBENE DERIVATIVES AS IMPROVED VASCULAR TARGETING AGENTS

Details for Australian Patent Application No. 2002361579 (hide)

Owner OXIGENE, INC.

Inventors GARNER, Charles, Manly, III; KANE, Robert, Ronald; PINNEY, Kevin, G.; PREZIOSO, Joseph, Anthony; CHAPLIN, David, J.

Pub. Number AU-A-2002361579

PCT Number PCT/US02/34497

PCT Pub. Number WO2003/035008

Priority 60/337,348 26.10.01 US

Filing date 28 October 2002

Wipo publication date 6 May 2003

Event Publications

10 April 2003 Complete Application Filed

  Priority application(s): 60/337,348 26.10.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-A-2002361579

18 May 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002361580-ADVANCED EXPOSURE TECHNIQUES FOR PROGRAMMABLE LITHOGRAPHY

2002361578-PULSED ELECTRIC FIELDMETHOD AND APPARATUS FOR PREVENTING BIOFOULING ON AQUATIC SURFACES